Quick Summary
A SEBI registered research analyst can trade their own money, but not however they like. The rule that matters is simple: they cannot trade in a stock they are recommending to you, from 30 days before their report until 5 days after it. Outside that window, and in stocks they have not recommended, they are free to trade like anyone else. They must also tell you if they hold the stock they are advising you on. This one rule exists to stop an analyst profiting at your expense. This page explains exactly where the line sits, and what to do if it was crossed.
It is a smart thing to ask, because an analyst who trades the very stocks they recommend has a clear reason to mislead you.
SEBI thought about exactly this, and built a rule to prevent it.
A registered analyst can trade; that part is allowed, but there is a firm line around the stocks they advise on. Here is where that line sits, in plain terms, and what it means for you.
Can SEBI Registered Research Analyst Do Trading?
The short answer is yes, a registered research analyst can trade in the market with their own money. Being an analyst does not bar them from being an investor too.
But that freedom comes with one important restriction, and it exists entirely to protect you.
An analyst cannot trade in the same securities they are recommending to their clients, within a set window around their advice.
They can invest, they can hold a portfolio, they can buy and sell, but not in a way that lets them cash in on the very calls they are giving you.
These rules are part of a bigger set that every SEBI registered research analyst has to follow, all meant to keep their advice honest.
So the honest answer is not a flat yes or no.
It is: yes, they can trade, but not the stocks they are telling you to trade, not around the time they are telling you.
Everything below explains that line.
Which Stocks Can’t a Research Analyst Trade?
This is the heart of the rule, and it comes from Regulation 16(2) of the SEBI (Research Analysts) Regulations, 2014.
The regulation sets a clear no-trading window.
An analyst, along with their team and close associates, cannot deal or trade in a security they recommend or follow, and that window has two halves:
- 30 days before the report: they cannot quietly buy the stock ahead of publishing. Otherwise they could load up first, tell thousands of subscribers to buy, and watch their own holding jump as the crowd piles in.
- 5 days after the report: they still cannot trade it. This stops them dumping their shares onto the very followers they just told to buy, the moment the price ticks up.
That 30-day-before, 5-day-after window is the single most important thing to understand here.
It is the fence SEBI built between an analyst’s advice to you and their own wallet.
Can a Research Analyst Trade Other Stocks?
Yes, and this is where a lot of confusion clears up.
The restriction is specific.
It applies only to the securities the analyst actually recommends or follows.
Every other stock in the market is fair game.
If an analyst has never given a call on a particular company, they can trade it freely, buy it, sell it, hold it, with no special window at all.
Their personal portfolio can be full of stocks they have never advised anyone on, and that is perfectly fine.
So the rule is not “an analyst cannot trade.”
It is “an analyst cannot trade the specific stocks they are advising you on, around the time of that advice.” That is a narrow, targeted fence, not a blanket ban.
It sits alongside the other limits on what a SEBI registered research analyst can do, each one drawing a clear boundary around the role.
Can a Research Analyst Trade in F&O and Options?
This one trips people up, because futures and options have monthly expiries, and the 30-day window feels awkward against them. It is a genuine question analysts themselves ask.
The principle stays the same: it is about whether the instrument is the one being recommended.
If an analyst gives a client a call on a specific option, say a particular strike and expiry, then that exact instrument falls under the restriction.
But if they personally trade a different instrument, a different strike, a different underlying, or a different security altogether, even while holding a similar market view, that personal trade is generally allowed, because it is not the same thing they recommended to you.
The line, in other words, is drawn around the specific recommended security, not around the analyst’s opinion of the market.
Their view can be the same; what they cannot do is trade the exact instrument they told you to trade, inside the window.
Why Can’t They Trade What They Recommend?
It is worth understanding the reason, because once you see it, you will spot the danger it prevents.
The whole point is to remove the conflict of interest.
When an analyst holds a stock and then publicly urges everyone to buy it, they are no longer giving you neutral research; they are talking up their own position.
In plain terms, they profit from their own advice, and that is exactly what the rule shuts down.
Think about what it does to you
. You act on the call believing it is honest analysis. In reality, you may be the buyer whose demand lifts the price so the analyst can sell into it at a profit. Their gain comes directly from your action.
There is a second part to this too. An analyst is not allowed to trade against their own published advice either. They cannot tell you to buy a stock while quietly betting on it to fall.
Their personal trades cannot contradict the very calls they hand you.
SEBI’s 30-and-5 window, along with this rule, kills the incentive to game you.
If an analyst cannot trade the stock around their own recommendation, and cannot position themselves against it, they have nothing personal riding on whether you follow the call, which is exactly how honest research is supposed to work.
The rule is not red tape. It is there so the advice you pay for is about your interest, not the analyst’s.
What Must an Analyst Tell You About Their Trades?
Beyond the no-trading window, there is a second layer of protection: disclosure.
A registered analyst is required to tell you, in their report, whether they or their close family hold any financial interest in the security they are recommending.
You will often see a line at the bottom of a genuine research report stating whether the analyst has a position in the stock.
This matters because it puts the information in your hands before you act.
If an analyst discloses that they already hold the stock, you can weigh their call with that in mind.
An analyst who hides their holdings, or gives calls with no disclosure at all, is skipping a duty that exists purely for your benefit.
So when you read a research report, look for that disclosure. Its presence is a sign of an analyst playing by the rules. Its absence is a reason to be careful.
When Trading Turns Into Taking Over Your Account?
So far this has been about an analyst trading inside or outside the rules.
It is worth knowing what happens when an analyst does not just bend the trading window, but uses their position against you directly.
There are two levels to this, and they are not the same thing; one is about the analyst’s own trades, the other is about yours.
Knowing which is which tells you how serious your situation is.
- Trading on their own calls: the analyst secretly holds a stock and then pushes it to subscribers, profiting as your buying lifts the price. This is the trading-window rule being deliberately broken.
- Handling your account: a step further, and far more serious. The analyst takes control of your account or places trades in it, which no analyst is ever authorised to do. This is no longer about their trading; it is about yours.
That second level is a serious breach in its own right, and we cover it in full on our page: unauthorized trading by a research analyst.
The thread connecting both is the same: the analyst’s own gain should never come from your trades.
The moment it does, a line has been crossed that gives you every right to act, and if an analyst went as far as running your trades for you, that specific situation is one we walk through on our page: registered research analyst ran my account.
Suspect your analyst was trading the very stocks they pushed on you?
We will look at the calls you were given against what the analyst was actually holding or doing, work out whether the conflict-of-interest rules were broken, and help you act on it.
What to Do If an Analyst Traded Against You?
If you believe an analyst recommended a stock they were quietly trading themselves, or hid a financial interest they were supposed to disclose, that is a genuine violation you can raise, and because they are registered, there is a formal path to do it.
Start by keeping the evidence: the research reports or calls you received, the dates, and any proof of what the analyst was holding or promoting.
Raise it with the firm first. If that leads nowhere, you can complete your SEBI SCORES login and lodge the complaint formally, with SEBI monitoring the response.
If it stays unresolved, the matter moves to SMART ODR for conciliation, and on to arbitration as a final step.
Our full guide on where to complain against SEBI research analyst walks you through each stage and what it can realistically win back.
Conclusion
So, can a SEBI registered research analyst trade? Yes, but with one line they cannot cross.
They are free to invest their own money, and free to trade any stock they have not recommended.
What they cannot do is trade the securities they are advising you on, from 30 days before their report to 5 days after, and they must disclose any interest they hold in what they recommend.
That single rule is quietly working in your favour every time you read an honest research report.
It keeps the analyst’s advice pointed at your gain, not theirs. And if you ever find it was ignored, you are not stuck with the consequences; the same rules the analyst broke are the ones that let you hold them to account.
Report. Recover. Stay Fraud Free.
Frequently Asked Questions
Not around their recommendation. Under Regulation 16(2), an analyst cannot trade a security they recommend or follow for 30 days before and 5 days after publishing their report on it. This window removes the incentive to profit from their own calls.
Yes, freely. The restriction only covers securities the analyst actually recommends or follows. Any other stock can be bought, sold, or held with no special window, so an analyst's personal portfolio can contain plenty of names they have never advised on.
It applies to the specific instrument recommended. If an analyst recommends a particular option, they cannot personally trade that same instrument in the window. A different strike, expiry, or underlying is generally allowed, even if their market view is similar, because it is not the recommended security.
Yes. A registered analyst must disclose in their report whether they or close family hold a financial interest in the recommended security. A genuine report carries this line. Missing or hidden disclosures are a warning sign worth taking seriously.
That points to a conflict-of-interest breach you can raise formally. Save the calls, dates, and any proof of their holdings, take it up with the firm, and escalate through SCORES, SMART ODR, and arbitration if needed. Documented evidence is what carries the complaint.
Add us as a preferred source on Google »
